Development and validation of an ELISA to study panitumumab pharmacokinetics
Résumé
Panitumumab is a monoclonal antibody directed against EGFR that is approved for the treatment of metastatic colorectal cancer. To investigate its pharmacokinetics and concentration-response relationship, a validated assay is required.